Clinical Trial: A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465731) titled 'A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine' on March 06.

Brief Summary: The purpose of this trial is to assess relative bioavailability of centanafadine (CTN) SR tablet to CTN QD XR capsule in healthy adult participants.

Study Start Date: Oct. 27, 2022

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Centanafadine SR

Oral tablets.

DRUG: Centanafadine QD XR

Oral capsules.

Recruitment Status: COMPLETED

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Published by HT Digital Content Services with ...